Effectiveness and safety of different traditional Chinese medicines for Coronavirus disease 2019 A protocol for systematic review and network meta-analysis

코로나 바이러스 질병 2019에 대한 다른 전통적인 중국 의약품의 효과 및 안전성 및 네트워크 메타 분석을위한 프로토콜

Published on
Journal: Medicine
[저자] Bo Huang, Yingfeng Liu, Chiheng Pi, Shifan Yan, Fusheng Li
[Category] COVID-19, MERS, meta-analysis,
PMC URL    [DOI] 10.1097/MD.0000000000026676    
[Article Type] 3800
[Source] PMC

Abstract Introduction: The effectiveness of different Traditional Chinese Medicine in the treatment of COVID-19 is worthy of attention, but the efficacy and safety of different Traditional Chinese Medicine in the treatment of COVID-19 have not yet been compared, based on network meta-analysis. Methods and analysis: The 2 members independently searched 7 databases according to the retrieval strategy, and the retrieval time was from the beginning of the establishment of the database to June 19, 2021. Then the title was imported into the EndNote Software AQ8 (V.X9), and the duplicate literature was deleted successively, the nonconforming articles were deleted in the title reading, and finally the full text was read to determine the articles included in the study. The Cochrane Collaboration’s Tool will be used to evaluate the article quality, and Stata Statistical Software (Version 14.0, Stata Corporation, College Station, TX) will be used for data analysis. Levels of evidence are evaluated according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) instrument. Results: The efficacy and safety of different Traditional Chinese Medicine in the treatment of COVID-19 were evaluated, and the order was determined according to the value of sucre. Conclusion: This study will provide evidence for the treatment of COVID-19 with TCM therapy, and provide ideas for the clinical treatment of COVID-19. INPLASY registration number: No. INPLASY202160092.

All Keywords
【저자키워드】 COVID-19, protocol, systematic review, Traditional Chinese medicine, 【초록키워드】 Treatment, therapy, Network meta-analysis, Traditional Chinese medicine, database, Medicine, Data analysis, Effectiveness, Efficacy and safety, assessment, development, collaboration, Evidence, TCM, Clinical treatment, registration number, Chinese, Version, title, clinical treatment of COVID-19, article, Stata Corporation, Stata Statistical Software, sucre, college, evaluated, was determined, searched, determine, deleted, Level, Station, Traditional, used to evaluate, 【제목키워드】 Coronavirus disease 2019,
초록 서론: COVID-19 치료에 있어 다른 한약의 효과는 주목할만한 가치가 있지만, COVID-19 치료에 있어 다른 한약의 효능과 안전성은 네트워크 메타- 분석. 방법 및 분석: 2명의 구성원이 검색 전략에 따라 7개의 데이터베이스를 독립적으로 검색하였으며, 검색 시간은 데이터베이스 구축 초기부터 2021년 6월 19일까지였다. 이후 제목을 EndNote Software AQ8(V. X9), 중복 문헌을 순차적으로 삭제하고, 표제 독해에서 부적합 논문을 삭제하고, 최종적으로 전문을 낭독하여 연구에 포함된 논문을 결정하였다. Cochrane Collaboration's Tool은 기사 품질을 평가하는 데 사용되며 Stata Statistical Software(버전 14.0, Stata Corporation, College Station, TX)는 데이터 분석에 사용됩니다. 증거 수준은 GRADE(Grading of Recommendations Assessment, Development and Evaluation) 도구에 따라 평가됩니다. 결과: COVID-19 치료에서 다양한 한방의 효능과 안전성을 평가하고 sucre 값에 따라 순서를 결정했습니다. 결론: 이 연구는 한의학 요법으로 COVID-19를 치료하는 증거를 제공하고 COVID-19의 임상 치료에 대한 아이디어를 제공할 것입니다. INPLASY 등록 번호: 번호 INPLASY202160092.